References
- Adams JM, Cory S (1998). The Bcl-2 protein family: arbiters of cell survival. Science, 281, 1322-6. https://doi.org/10.1126/science.281.5381.1322
- Butt AJ, Williams AC, (2001). IGFBP-3 and apoptosis--a licenseto kill? Apoptosis, 6, 199-205. https://doi.org/10.1023/A:1011388710719
- Chang CC, Hung CM, Yang YR, et al (2013). Sulforaphaneinduced cell cycle arrest in the G2/M phase via the blockade of cyclin B1/CDC2 in human ovarian cancer cells. J Ovarian Res, 6, 41. https://doi.org/10.1186/1757-2215-6-41
- Chen X, Liu J, Chen SY, (2013). Sulforaphane protects against ethanol-induced oxidative stress and apoptosis in neuralcrest cells by the induction of Nrf2-mediated antioxidant response. Br J Pharmacol, 169, 437-48. https://doi.org/10.1111/bph.12133
- Dolcet X, Llobet D, Pallares J, et al (2005). NF-kB in development and progression of human cancer. Virchows Arch, 446, 475-82. https://doi.org/10.1007/s00428-005-1264-9
- Fang Y, Sun H, Zhai J, et al (2011). Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line. Asian Pac J Cancer Prev, 12, 2721-6.
- Ferreira U, Matheus WE, Nardi Pedro R, et al (2007). Primary invasive versus progressive invasive transitional cell bladdercancer: multicentric study of overall survival rate.Urol Int, 79, 200-3 https://doi.org/10.1159/000107950
- Frydoonfar HR, McGrath DR, Spigelman AD (2004).Sulforaphane inhibits growth of a colon cancer cell line.Colorectal Dis, 6, 28-31. https://doi.org/10.1111/j.1463-1318.2004.00488.x
- Ge WQ, Pu JX, Zheng SY (2012). Clinical application of the adenosine triphosphate-based response assay in intravesicalchemotherapy for superficial bladder cancer. Asian Pac J Cancer Prev, 13, 689-92. https://doi.org/10.7314/APJCP.2012.13.2.689
- Herman-Antosiewicz A, Xiao H, Lew KL, et al (2007). Inductionof p21 protein protects against sulforaphane-induced mitoticarrest in LNCaP human prostate cancer cell line. Mol Cancer Ther, 6, 1673-81. https://doi.org/10.1158/1535-7163.MCT-06-0807
- Johnston N (2004). Sulforaphane halts breast cancer cell growth.Drug Discov Today, 9, 908. https://doi.org/10.1016/S1359-6446(04)03267-2
- Kalluri HS, Dempsey RJ (2011). IGFBP-3 inhibits theproliferation of neural progenitor cells. Neurochem Res,36, 406-11. https://doi.org/10.1007/s11064-010-0349-2
- Kim HS, Lee WJ, Lee SW, et al (2010). Insulin-like growth factorbinding protein-3 induces G1 cell cycle arrest with inhibitionof cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells. Horm Metab Res, 42, 165-72. https://doi.org/10.1055/s-0029-1243190
- Kim MR, Zhou L, Park BH, et al., (2011). Induction of G (2)/M arrest and apoptosis by sulforaphane in human osteosarcomaU2-OS cells. Mol Med Rep, 4, 929-34.
- Kleszczynski K, Ernst IM, Wagner AE, et al (2013). Sulforaphaneand phenylethyl isothiocyanate protect human skin against UVR-induced oxidative stress and apoptosis: Role of Nrf2-dependent gene expression and antioxidant enzymes.Pharmacol Res, 78, 28-40. https://doi.org/10.1016/j.phrs.2013.09.009
- Lee YC, Jogie-Brahim S, Lee DY, et al (2011). Insulin-likegrowth factor-binding protein-3 (IGFBP-3) blocks the effectsof asthma by negatively regulating NF-kappaB signalingthrough IGFBP-3R-mediated activation of caspases. J Biol Chem, 286, 17898-909. https://doi.org/10.1074/jbc.M111.231035
- Montgomery JS, Miller DC, Weizer AZ, et al (2013). Quality indicators in the management of bladder cancer. J Natl Compr Canc Netw, 11, 492-500. https://doi.org/10.6004/jnccn.2013.0061
- Shen G, Xu C, Chen C, et al (2006). p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 bysulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Cancer Chemother Pharmacol, 57, 317-27. https://doi.org/10.1007/s00280-005-0050-3
- Wang M, Chen S, Wang S, et al (2012). Effects of phytochemicalssulforaphane on uridine diphosphate-glucuronosyltransferaseexpression as well as cell-cycle arrest and apoptosis in humancolon cancer Caco-2 cells. Chin J Physiol, 55, 134-44.
- Wang Z, Liang Z, Liu J, et al (2013). Expression and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues from patients with non-small cell lung cancer. Onco Targets Ther, 6, 1437-44.
- Williams AC, Smartt H, H-Zadeh AM, et al (2007). Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-kappaB. Cell Death Differ,14, 137-45. https://doi.org/10.1038/sj.cdd.4401919
- Zhang GJ, Zhang Z (2013). Effect of Bcl-2 on apoptosis and transcription factor NF-kappaB activation induced byadriamycin in bladder carcinoma BIU87 cells. Asian Pac J Cancer Prev, 14, 2387-91. https://doi.org/10.7314/APJCP.2013.14.4.2387
Cited by
- Expression and Underlying Roles of IGFBP-3 in Paclitaxel-Treated Gastric Cancer Sgc-7901 Cells vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5741
- Sulforaphane (SFN): An Isothiocyanate in a Cancer Chemoprevention Paradigm vol.2, pp.3, 2015, https://doi.org/10.3390/medicines2030141
- Wogonoside induces apoptosis in Bel-7402, a hepatocellular carcinoma cell line, by regulating Bax/Bcl-2 pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3408
- Cruciferous Vegetables, Isothiocyanates, and Bladder Cancer Prevention vol.62, pp.18, 2018, https://doi.org/10.1002/mnfr.201800079